Cost-effectiveness of cabotegravir versus tenofovir alafenamide plus emtricitabine versus tenofovir disoproxil fumarate plus emtricitabine for pre-exposure prophylaxis to prevent HIV-1 transmission in gay, bisexual and other men that have sex with men Philip Erick Wikman-Jorgensen; Marta Ruiz-Algueró; Carlos Iniesta; Federico Pulido; Jara Llenas-García;